Limited ESA Use in COVID-19 Patients Recommended
Anemia in patients hospitalized with COVID-19 can be severe, but in most cases, clinicians should limit their use of erythropoiesis-stimulating agents.
All articles by Natasha Persaud
Adverse Drug Reactions Common in CKD
Nearly a third of serious adverse drug reactions in patients with chronic kidney disease may be preventable, according to investigators.
Co-Dispensing of Benzodiazepines and Opioids Dangerous in HD
Patients on hemodialysis who use opioids concurrently with a short-acting benzodiazepine are especially at risk for early death, a study found.
Acute Kidney Injury Risk Up With RAASi, Diuretic Use
Clinicians should weigh the benefits and risks of renin-angiotensin-aldosterone-system inhibitors and diuretics, according to investigators.
Immune Checkpoint Inhibitors May Increase Risk of Acute Kidney Injury
In a real-world study, 3% of AKI events potentially related to use of immune checkpoint inhibitor therapy — a higher rate than reported in clinical trials.
Roxadustat Superior to Epoetin Alfa in New Dialysis Patients
Newly released safety data also show that roxadustat is associated with reduced cardiovascular risks compared with epoetin alfa.
Apalutamide Plus ADT for mCSPC Maintains Health-Related Quality of Life
In the TITAN trial, health-related quality of life did not worsen with the addition of apalutamide to ADT versus placebo for patients with metastatic castration-sensitive prostate cancer.
Prostate Cancer Risk May Be Increased in Fathers Using Assisted Reproduction
In a study, fathers who used intra-cytoplasmic sperm injection or in vitro fertilization had higher risk for prostate cancer than men who conceived naturally.
